Gene · 2012
Papers1,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of GALNT12 as a Novel Potential Diagnostic and Prognostic Marker for Esophageal Squamous Cell Carcinoma by Integrated Bioinformatics Analysis. | Digestion | 2025 | 40334654 | PubTator, text mining | PubMed |
| Prediction of reaction kinetics for CL-20 and host-guest crystals under high temperature and pressure using neuroevolution potential. | J Chem Phys | 2025 | 40322991 | PubTator, text mining | PubMed |
| Effect of miR-654-3p targeting EMP1 on osteoblast activity and differentiation in delayed fracture healing. | J Orthop Surg Res | 2025 | 40156038 | PubTator, text mining | PubMed |
| Educational and Clinical Applications of a Web- and Android-Based Telemedicine Platform to Expand Rural Health Care in Ecuador. | Telemed Rep | 2025 | 40151789 | PubTator, text mining | PubMed |
| About proteins of a siphophage tail tip complex reverting to their pre-ejection fold after DNA ejection. | Nat Commun | 2025 | 40133284 | PubTator, text mining | PubMed |
| Reply to: About proteins of a siphophage tail tip complex reverting to their pre-ejection fold after DNA ejection. | Nat Commun | 2025 | 40133277 | PubTator, text mining | PubMed |
| Preparation of CL-20 with Controllable Particle Size Using Microfluidic Technology. | Molecules | 2025 | 40076398 | PubTator, text mining | PubMed |
| Identification of E3 ubiquitin ligase-based molecular subtypes and prognostic signature regarding prognosis and immune landscape in bladder cancer. | Cancer Cell Int | 2025 | 40016750 | PubTator, text mining | PubMed |
| Tumor cell-derived EMP1 is essential for cancer-associated fibroblast infiltration in tumor microenvironment of triple-negative breast cancer. | Cell Death Dis | 2025 | 40016223 | PubTator, text mining | PubMed |
| Nomogram construction based on characteristic genes and clinical variables to predict the risk of multiple organ dysfunction syndrome caused by influenza in children. | Transl Pediatr | 2025 | 39944873 | PubTator, text mining | PubMed |
| EZH2 serves as a viable therapeutic target for myeloma-induced osteolytic bone destruction. | Nat Commun | 2025 | 39885217 | PubTator, text mining | PubMed |
| Molecular dynamics simulation of CL-20 based high temperature resistant PBX. | J Mol Model | 2025 | 39833581 | PubTator, text mining | PubMed |
| CT-based Machine Learning Radiomics Modeling: Survival Prediction and Mechanism Exploration in Ovarian Cancer Patients. | Acad Radiol | 2025 | 39827000 | PubTator, text mining | PubMed |
| Identifying genetic susceptibility loci associated with human coronary artery disease. | PLoS One | 2025 | 39787106 | PubTator, text mining | PubMed |
| HPV-Associated Gene Signatures in Bladder Cancer: A Comprehensive Prognostic Model and its Implications in Immunotherapy. | Int J Med Sci | 2025 | 39744172 | PubTator, text mining | PubMed |
| Mechanism of S100A9-mediated astrocyte activation via TLR4/NF-κB in Parkinson's disease. | Int Immunopharmacol | 2025 | 39724736 | PubTator, text mining | PubMed |
| Transcriptome-Based Network Analysis Related to Histone Deacetylase Genes and Identified EMP1 as a Potential Biomarker for Prognosis in Bladder Cancer. | Clin Genitourin Cancer | 2025 | 39603145 | PubTator, text mining | PubMed |
| Acute myeloid leukemia stem cell signature gene EMP1 is not an eligible therapeutic target. | Pediatr Res | 2025 | 38879624 | PubTator, text mining | PubMed |
| Transmembrane proteins in grape immunity: current knowledge and methodological advances. | Front Plant Sci | 2024 | 39759230 | PubTator, text mining | PubMed |
| Talent management intervention towards performance outcomes of Jordanian telecommunication companies: mediating role of perceived organizational support. | BMC Psychol | 2024 | 39741331 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2012/papers?page=5